Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

Ortega, Alberto García; Jiménez, David; Pedro-Tudela, Ana; Pérez-Ductor, Cristina; Fernández-Capitán, Carmen; Falgá, Conxita; Skride, Andris; Siniscalchi, Carmine; Weinberg, Ido; Monreal, Manuel

doi:10.1016/j.arbres.2023.12.016

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is an international journal that publishes original studies whose content is based upon results of research initiatives dealing with several aspects of respiratory medicine including epidemiology, respiratory physiology, pathophysiology of respiratory diseases, clinical management, thoracic surgery, pediatric lung diseases, respiratory critical care, respiratory allergy and translational research. Other types of articles such as editorials, reviews, and different types of letters are also published in the journal. Additionally, the journal expresses the voice of the following scientific societies: the Spanish Respiratory Society of Pneumology and Thoracic Surgery (SEPAR; https://www.separ.es/), the Latin American Thoracic Society (ALAT; https://alatorax.org/), and the Iberian American Association of Thoracic Surgery (AIACT; http://www.aiatorax.com/).

It is a monthly journal in which all manuscripts are sent to peer-review and handled by the editor or an associate editor from the team and the final decision is made on the basis of the comments from the expert reviewers and the editors. The journal is published solely in English. All the published data is composed of novel manuscripts not previously published in any other journal and not being in consideration for publication in any other journal..

The journal is indexed at Science Citation Index Expanded, Medline/Pubmed, Embase and SCOPUS. Access to any published article is possible through the journal's web page as well as from Pubmed, ScienceDirect, and other international databases. Furthermore, the journal is also present in X, Facebook and Linkedin. Manuscripts can be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

8.7

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

3.5

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.464

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.482

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 60. Issue 3.

Pages 143-152 (March 2024)

Export reference

Download PDF

More article options

Statistics

Vol. 60. Issue 3.

Pages 143-152 (March 2024)

Original Article

DOI: 10.1016/j.arbres.2023.12.016

Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

Visits

868

Download PDF

Alberto García Ortegaa,b,

Corresponding author

albortgva@gmail.com

Corresponding author.

, David Jiménezc,d,e, Ana Pedro-Tudelaa, Cristina Pérez-Ductorf, Carmen Fernández-Capitáng, Conxita Falgáh, Andris Skridei, Carmine Siniscalchij, Ido Weinbergk, Manuel Monreald,l, the RIETE investigators ◊

a Respiratory Department, Hospital Dr. Peset, Valencia, Spain

b Medical Research Institute Hospital La Fe (IISLAFE), Valencia, Spain

c Respiratory Department, Hospital Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain

d CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain

e Medicine Department, Universidad de Alcalá, Madrid, Spain

f Emergency Department, Hospital Dr. Peset, Valencia, Spain

g Department of Internal Medicine, Hospital Universitario La Paz, Madrid, Spain

h Department of Internal Medicine, Hospital de Mataró, Barcelona, Spain

i Department of Cardiology, Ospedale Pauls Stradins Clinical University Hospital, Riga Stradiņš University, Riga, Latvia

j Department of Angiology, Azienda Ospedaliera Universitaria, Parma, Italy

k Department of Cardiology, Massachusetts General Hospital, Boston, MA, USA

l Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM – Universidad Católica San Antonio de Murcia, Spain

This item has received

868 Visits

3 Cites

Article information

Abstract

Full Text

Bibliography

Download PDF

Statistics

Figures (2)

Tables (6)

Table 1. Clinical characteristics at baseline in the first 100,000 patients with acute VTE enrolled in the RIETE registry, according to age.

Table 2. Initial VTE presentation in the first 100,000 patients recruited in the RIETE registry, according to age.

Table 3. Treatment strategies for initial and long-term anticoagulant therapy in the first 100,000 patients in the RIETE registry, according to age.

Table 4. Thirty- and ninety-day outcomes in the first 100,000 patients in the RIETE registry, according to age.

Table 5. Multivariable model of predictors of 30-day all-cause mortality*.

Table 6. Thirty- and ninety-day outcomes in patients with acute pulmonary embolism (N=49,202) in the RIETE registry, according to age.

Show moreShow less

Additional material (1)

Abstract

Introduction

Although older adults represent a significant proportion of patients with venous thromboembolism (VTE), the data on the impact of age-related differences in the clinical presentation, management, and outcomes of VTE are scarce.

Methods

We analyzed data from the RIETE registry database, an ongoing global observational registry of patients with objectively confirmed VTE, to compare patient characteristics, clinical presentation, treatments, and outcomes between elderly (≥70 years) vs. non-elderly (<70 years) patients.

Results

From January 2001 to March 2021, 100,000 adult patients were enrolled in RIETE. Elderly patients (47.9%) were more frequently women (58.2% vs. 43.5%), more likely had unprovoked VTE (50.5% vs. 45.1%) and most often presented with severe renal failure (10.2% vs. 1.2%) and acute pulmonary embolism (PE) (vs. deep vein thrombosis) (54.3% vs. 44.5%) compared to non-elderly patients (p<0.001 for all comparisons). For the PE subgroup, elderly patients more frequently had non-low risk PE (78.9% vs. 50.7%; p<0.001), respiratory failure (33.9% vs. 21.8%; p<0.001) and myocardial injury (40.0% vs. 26.2%; p<0.001) compared to non-elderly patients. Thrombolysis (0.9% vs. 1.7%; p<0.001) and direct oral anticoagulants (8.8% vs. 11.8%; p<0.001) were less frequently administered to elderly patients. Elderly patients showed a significantly higher 30-day all-cause mortality (adjusted odds ratio [OR] 1.36, 95%CI: 1.22–1.52) and major bleeding (OR, 2.08; 95%CI, 1.85–2.33), but a lower risk of 30-day VTE recurrences (OR, 0.62, 95%CI, 0.54–0.71).

Conclusions

Compared with non-elderly patients, elderly patients had a different VTE clinical profile. Advanced therapies were less frequently used in older patients. Age was an independent predictor of mortality.

Keywords:

Pulmonary embolism

Venous thromboembolism

Anticoagulation

Mortality

Bleeding

Recurrences

Abbreviations:

DVT

DOAC

ECMO

IVC